ARTICLES BY THIS AUTHOR
- 11/12/2019
Breckenridge gets FDA green light for generic Tarceva
Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019. - 11/12/2019
Bartell Drugs launches Instacart delivery
Bartell's, which introduced NimbleRx for prescription delivery early this year, is launching Instacart. - 11/12/2019
Teva taps Eli Kalif as executive vice president, CFO
Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22. - 11/12/2019
Mylan-Upjohn combination to be called Viatris
The Viatris name will be effective upon closing of the combination of Mylan and Upjohn, which is expected to occur in mid 2020. - 11/12/2019
Diplomat posts Q3 loss along with drop in PBM segment
Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment - 11/11/2019
KKR reportedly approaches Walgreens Boots Alliance on leveraged buyout
Private equity firm KKR has reportedly been preparing a proposal to take Walgreens Boots Alliance private. - 11/11/2019
Glenmark gets FDA nod for generic Epiduo
Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA. - 11/11/2019
Rite Aid Foundation donates $75K to California wildfire relief efforts
The Rite Aid Foundation's $75,000 donation to the American Red Cross will be divided to help relief efforts in Northern and Southern California. - 11/11/2019
Foamix, Menlo Therapeutics to merge
Foamix and Menlo’s merger will result in a combined company focused on the dermatology space. - 11/8/2019
Celgene gets FDA green light for Reblozyl
Celgene’s Reblozyl is the first therapy to treat patients with a rare blood disorder.